APA (7th ed.) Citation

S, S., JN, E., C, R., CD, B., U, P., H, S., . . . C, T. (2025). The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML. British journal of haematology, 206(5), 1373. https://doi.org/10.1111/bjh.20027

Chicago Style (17th ed.) Citation

S, Stasik, et al. "The IKZF1 N159S Mutation Is Associated with Poor Outcome and a Distinct Molecular Profile in Adult Patients with AML." British Journal of Haematology 206, no. 5 (2025): 1373. https://doi.org/10.1111/bjh.20027.

MLA (9th ed.) Citation

S, Stasik, et al. "The IKZF1 N159S Mutation Is Associated with Poor Outcome and a Distinct Molecular Profile in Adult Patients with AML." British Journal of Haematology, vol. 206, no. 5, 2025, p. 1373, https://doi.org/10.1111/bjh.20027.